交易 Ironwood - IRWD CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
价差 | - | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.025457% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.003235% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Ironwood Pharmaceuticals Inc ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平仓 | Change | Change (%) | 開倉 | High | Low |
---|
Ironwood Events
时间(协调世界时) (UTC) | 国家/地区 | 事件 |
---|---|---|
Tuesday, June 20, 2023 | ||
时间(协调世界时) (UTC) 13:00 | 国家/地区 US
| 事件 Ironwood Pharmaceuticals Inc Annual Shareholders Meeting Ironwood Pharmaceuticals Inc Annual Shareholders MeetingForecast -Previous - |
Wednesday, August 2, 2023 | ||
时间(协调世界时) (UTC) 12:30 | 国家/地区 US
| 事件 Q2 2023 Ironwood Pharmaceuticals Inc Earnings Release Q2 2023 Ironwood Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
Wednesday, November 1, 2023 | ||
时间(协调世界时) (UTC) 12:30 | 国家/地区 US
| 事件 Q3 2023 Ironwood Pharmaceuticals Inc Earnings Release Q3 2023 Ironwood Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 410.596 | 413.753 | 389.523 | 428.413 | 346.639 |
收入 | 410.596 | 413.753 | 389.523 | 428.413 | 346.639 |
收入成本,共计 | 0 | 0 | 3.136 | 23.875 | 32.751 |
毛利 | 410.596 | 413.753 | 386.387 | 404.538 | 313.888 |
总营业费用 | 160.259 | 181.494 | 246.583 | 339.267 | 497.309 |
销售/一般/行政费用,总计 | 115.994 | 111.242 | 141.784 | 173.104 | 221.818 |
研究与开发 | 44.265 | 70.405 | 88.062 | 115.044 | 101.06 |
Depreciation / Amortization | 0 | 8.111 | |||
异常费用(收入) | 0 | -0.153 | 13.601 | 27.244 | 164.614 |
Other Operating Expenses, Total | 0 | -31.045 | |||
营业收入 | 250.337 | 232.259 | 142.94 | 89.146 | -150.67 |
利息收入(费用),非经营净值 | 2.085 | -31.602 | -34.103 | -30.717 | -43.476 |
税前净收入 | 252.422 | 200.657 | 108.861 | 58.943 | -194.146 |
税后净收入 | 175.065 | 528.448 | 106.176 | 58.943 | -194.146 |
未计算非常项目前的净收益 | 175.065 | 528.448 | 106.176 | 58.943 | -194.146 |
净收入 | 175.065 | 528.448 | 106.176 | 21.505 | -282.368 |
普通股股东可获收益 (不含非经常性项目) | 175.065 | 528.448 | 106.176 | 58.943 | -194.146 |
普通股股东可获收益 (含非經常性項目) | 175.065 | 528.448 | 106.176 | 21.505 | -282.368 |
摊薄净收入 | 179.514 | 528.448 | 106.176 | 21.505 | -282.368 |
摊薄后加权平均股 | 186.312 | 164.418 | 160.655 | 156.023 | 152.634 |
扣除特别项目的每股摊薄盈利 | 0.96351 | 3.21405 | 0.66089 | 0.37778 | -1.27197 |
每股正常摊薄盈利 | 0.96351 | 3.21345 | 0.74347 | 0.5524 | -0.19348 |
其他,净值 | 0 | 0 | 0.024 | 0.514 | 0 |
非常规项目总计 | 0 | -37.438 | -88.222 | ||
摊薄调整 | 4.449 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
总收入 | 104.061 | 107.199 | 108.637 | 97.231 | 97.529 |
收入 | 104.061 | 107.199 | 108.637 | 97.231 | 97.529 |
收入成本,共计 | |||||
毛利 | |||||
总营业费用 | 43.964 | 38.836 | 40.164 | 41.576 | 39.683 |
销售/一般/行政费用,总计 | 31.117 | 28.39 | 28.619 | 30.124 | 28.861 |
研究与开发 | 12.847 | 10.446 | 11.545 | 11.452 | 10.822 |
异常费用(收入) | 0 | 0 | |||
营业收入 | 60.097 | 68.363 | 68.473 | 55.655 | 57.846 |
利息收入(费用),非经营净值 | 5.764 | 3.902 | 1.434 | -1.87 | -1.381 |
税前净收入 | 65.861 | 72.265 | 69.907 | 53.785 | 56.465 |
税后净收入 | 45.714 | 48.867 | 50.317 | 37.08 | 38.801 |
未计算非常项目前的净收益 | 45.714 | 48.867 | 50.317 | 37.08 | 38.801 |
净收入 | 45.714 | 48.867 | 50.317 | 37.08 | 38.801 |
普通股股东可获收益 (不含非经常性项目) | 45.714 | 48.867 | 50.317 | 37.08 | 38.801 |
普通股股东可获收益 (含非經常性項目) | 45.714 | 48.867 | 50.317 | 37.08 | 38.801 |
摊薄净收入 | 46.829 | 49.981 | 51.429 | 38.192 | 39.911 |
摊薄后加权平均股 | 186.68 | 185.736 | 184.465 | 184.876 | 189.54 |
扣除特别项目的每股摊薄盈利 | 0.25085 | 0.2691 | 0.2788 | 0.20658 | 0.21057 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | 0.25085 | 0.2691 | 0.2788 | 0.20658 | 0.21057 |
其他,净值 | |||||
非常规项目总计 | |||||
摊薄调整 | 1.115 | 1.114 | 1.112 | 1.112 | 1.11 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 780.626 | 745.225 | 495.839 | 306.852 | 266.435 |
现金和短期投资 | 656.203 | 620.129 | 362.564 | 177.023 | 173.172 |
现金等价物 | 656.203 | 620.129 | 362.564 | 177.023 | 173.172 |
短期投资 | 0 | ||||
应收账款总额,净额 | 115.458 | 114.042 | 122.351 | 117.246 | 80.95 |
Accounts Receivable - Trade, Net | 115.458 | 114.042 | 122.351 | 117.246 | 80.95 |
Total Inventory | 0.648 | 0 | |||
Prepaid Expenses | 7.715 | 8.689 | 9.189 | 10.685 | 11.063 |
Total Assets | 1100.52 | 1126.93 | 559.238 | 402.748 | 332.05 |
Property/Plant/Equipment, Total - Net | 20.311 | 22.925 | 25.505 | 30.172 | 17.27 |
Property/Plant/Equipment, Total - Gross | 31.075 | 32.553 | 37.31 | 40.254 | 82.498 |
Accumulated Depreciation, Total | -10.764 | -9.628 | -11.805 | -10.082 | -65.228 |
Goodwill, Net | 0.785 | 0.785 | |||
Intangibles, Net | |||||
Other Long Term Assets, Total | 284.993 | 334.779 | 14.493 | 32.342 | 47.56 |
Total Current Liabilities | 25.525 | 161.698 | 32.173 | 40.929 | 119.524 |
Accounts Payable | 0.483 | 0.935 | 0.661 | 5.487 | 18.123 |
Accrued Expenses | 25.023 | 42.589 | 31.512 | 34.567 | 53.471 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 0 | 116.858 | 0 | 47.627 | |
Other Current Liabilities, Total | 0.019 | 1.316 | 0.875 | 0.303 | |
Total Liabilities | 448.141 | 521.016 | 496.598 | 495.999 | 528.421 |
Total Long Term Debt | 396.251 | 337.333 | 430.256 | 407.994 | 366.296 |
Long Term Debt | 396.251 | 337.333 | 430.256 | 407.994 | 366.138 |
Capital Lease Obligations | 0 | 0.158 | |||
Other Liabilities, Total | 26.365 | 21.985 | 34.169 | 47.076 | 42.601 |
Total Equity | 652.378 | 605.911 | 62.64 | -93.251 | -196.371 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
Common Stock | 0.154 | 0.162 | 0.161 | 0.158 | 0.154 |
Additional Paid-In Capital | 1348.6 | 1543.36 | 1528.54 | 1478.82 | 1394.6 |
Retained Earnings (Accumulated Deficit) | -696.376 | -937.608 | -1466.06 | -1572.23 | -1591.13 |
Other Equity, Total | 0 | ||||
Total Liabilities & Shareholders’ Equity | 1100.52 | 1126.93 | 559.238 | 402.748 | 332.05 |
Total Common Shares Outstanding | 154.027 | 162.036 | 160.617 | 157.536 | 154.415 |
Other Current Assets, Total | 1.25 | 2.365 | 1.735 | 1.25 | 1.25 |
Note Receivable - Long Term | 14.589 | 23.998 | 23.401 | 32.597 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 866.374 | 780.626 | 698.994 | 617.826 | 710.101 |
现金和短期投资 | 740.342 | 656.203 | 574.188 | 504.365 | 593.371 |
现金等价物 | 740.342 | 656.203 | 574.188 | 504.365 | 593.371 |
应收账款总额,净额 | 115.749 | 115.458 | 116.545 | 102.357 | 105.515 |
Accounts Receivable - Trade, Net | 115.749 | 115.458 | 116.545 | 102.357 | 105.515 |
Prepaid Expenses | 9.033 | 7.715 | 7.011 | 9.854 | 8.537 |
Other Current Assets, Total | 1.25 | 1.25 | 1.25 | 1.25 | 2.678 |
Total Assets | 1155.28 | 1100.52 | 1040.34 | 975.69 | 1083.38 |
Property/Plant/Equipment, Total - Net | 19.689 | 20.311 | 21.025 | 21.664 | 22.257 |
Note Receivable - Long Term | 0 | 14.589 | 14.439 | 14.289 | 14.143 |
Other Long Term Assets, Total | 269.214 | 284.993 | 305.886 | 321.911 | 336.88 |
Total Current Liabilities | 23.843 | 25.525 | 27.117 | 23.298 | 147.403 |
Accounts Payable | 0.118 | 0.483 | 0.795 | 0.317 | 0.532 |
Accrued Expenses | 23.725 | 25.023 | 26.321 | 22.829 | 25.391 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 448.425 | 448.141 | 449.281 | 442.807 | 565.598 |
Total Long Term Debt | 396.653 | 396.251 | 395.85 | 395.451 | 395.053 |
Long Term Debt | 396.653 | 396.251 | 395.85 | 395.451 | 395.053 |
Other Liabilities, Total | 27.929 | 26.365 | 26.314 | 24.058 | 23.142 |
Total Equity | 706.852 | 652.378 | 591.063 | 532.883 | 517.783 |
Common Stock | 0.155 | 0.154 | 0.153 | 0.153 | 0.155 |
Additional Paid-In Capital | 1357.36 | 1348.6 | 1336.15 | 1328.29 | 1350.27 |
Retained Earnings (Accumulated Deficit) | -650.662 | -696.376 | -745.243 | -795.56 | -832.64 |
Total Liabilities & Shareholders’ Equity | 1155.28 | 1100.52 | 1040.34 | 975.69 | 1083.38 |
Total Common Shares Outstanding | 155.346 | 154.027 | 153.319 | 153.176 | 155.115 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 120.581 | |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0 | 0.019 | 0.001 | 0.152 | 0.899 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 175.065 | 528.448 | 106.176 | 21.505 | -282.368 |
经营活动产生的现金 | 273.763 | 261.895 | 168.836 | 10.725 | -70.882 |
经营活动产生的现金 | 1.418 | 1.523 | 3.564 | 5.58 | 6.112 |
Amortization | 0 | 8.111 | |||
非现金物品 | 28.721 | 47.487 | 60.037 | 83.633 | 189.647 |
已付现金利息 | 5.745 | 7.216 | 7.216 | 17.584 | 18.235 |
营运资金的变化 | 2.82 | 17.731 | -0.941 | -99.993 | 7.616 |
投资活动产生的现金 | -0.136 | -0.265 | -1.842 | -11.144 | 88.866 |
资本支出 | -0.136 | -0.265 | -1.842 | -7.189 | -8.621 |
其他投资现金流量项目,总计 | 0 | -3.955 | 97.487 | ||
融资活动产生的现金 | -237.553 | -4.55 | 18.546 | -1.185 | 30.072 |
融资现金流项目 | 0 | -9.048 | -0.165 | ||
股票的发行(报废),净额 | -116.854 | -4.55 | 18.546 | -8.39 | 32.061 |
债务的发行(退还),净额 | -120.699 | 0 | 0 | 16.253 | -1.824 |
现金净变化 | 36.074 | 257.08 | 185.54 | -1.604 | 48.056 |
Cash Taxes Paid | 4.615 | 3.452 | 1.848 | ||
Deferred Taxes | 65.739 | -333.294 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 45.714 | 175.065 | 126.198 | 75.881 | 38.801 |
Cash From Operating Activities | 80.171 | 273.763 | 194.581 | 125.489 | 64.124 |
Cash From Operating Activities | 0.286 | 1.418 | 1.078 | 0.715 | 0.355 |
Non-Cash Items | 7.514 | 28.721 | 21.01 | 13.694 | 5.896 |
Changes in Working Capital | 9.605 | 2.82 | 0.685 | 5.605 | 4.364 |
Cash From Financing Activities | 3.981 | -237.553 | -240.359 | -241.156 | -90.873 |
Issuance (Retirement) of Stock, Net | 3.981 | -116.854 | -119.66 | -120.457 | -90.873 |
Net Change in Cash | 84.139 | 36.074 | -45.941 | -115.764 | -26.758 |
Deferred Taxes | 17.052 | 65.739 | 45.61 | 29.594 | 14.708 |
Cash From Investing Activities | -0.013 | -0.136 | -0.163 | -0.097 | -0.009 |
Capital Expenditures | -0.013 | -0.136 | -0.163 | -0.097 | -0.009 |
Other Investing Cash Flow Items, Total | |||||
Financing Cash Flow Items | |||||
Issuance (Retirement) of Debt, Net | -120.699 | -120.699 | -120.699 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 14.2993 | 22213467 | -610874 | 2023-03-31 | LOW |
Sarissa Capital Management, L.P. | Hedge Fund | 10.5506 | 16390000 | 0 | 2023-03-31 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.6117 | 14931427 | 222467 | 2023-03-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 6.7474 | 10481842 | -697736 | 2023-03-31 | LOW |
LSV Asset Management | Investment Advisor | 4.878 | 7577709 | -348688 | 2023-03-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 2.9854 | 4637753 | 263600 | 2023-03-31 | HIGH |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 2.967 | 4609079 | 946481 | 2023-03-31 | LOW |
Credit Suisse International | Research Firm | 2.5749 | 4000041 | 4000041 | 2023-03-31 | LOW |
Brown Capital Management, LLC | Investment Advisor | 2.5324 | 3933933 | -63112 | 2023-03-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 2.2665 | 3520855 | 203095 | 2023-03-31 | HIGH |
Victory Capital Management Inc. | Investment Advisor/Hedge Fund | 1.9507 | 3030332 | 127656 | 2023-03-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6954 | 2633804 | 118514 | 2023-03-31 | LOW |
Pacer Advisors, Inc. | Investment Advisor | 1.456 | 2261800 | 711756 | 2023-03-31 | HIGH |
Jane Street Capital, L.L.C. | Research Firm | 1.2397 | 1925882 | 1783342 | 2023-03-31 | HIGH |
Royce Investment Partners | Investment Advisor/Hedge Fund | 1.2142 | 1886247 | 210758 | 2023-03-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.1637 | 1807808 | 135157 | 2023-03-31 | LOW |
Invesco Capital Management LLC | Investment Advisor | 1.0495 | 1630403 | 43855 | 2023-03-31 | LOW |
Nuveen LLC | Pension Fund | 1.0332 | 1605096 | -204093 | 2023-03-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9795 | 1521628 | -1530093 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.9699 | 1506691 | 418419 | 2023-03-31 | LOW |
交易计算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Ironwood Company profile
关于 Ironwood
Ironwood Pharmaceuticals, Inc.是一家胃肠道(GI)保健公司,专注于未满足需求领域的胃肠道产品的开发和商业化,包括便秘肠易激综合症(IBS C)和慢性特发性便秘(CIC)。 该公司在人类治疗学业务领域运营。 其候选产品LINZESS(linaclotide)在美国和墨西哥适用于患有IBS-C或CIC的成年男性和女性,以及患有IBS-C的成年男性和女性。 其利那洛肽在加拿大以商标名CONSTELLA提供给患有IBS-C或CIC的成年男性和女性,并在某些欧洲国家提供给患有IBS-C的成年男性和女性。 公司的产品管道包括IW-3300,这是一种GC-C激动剂,可能用于治疗内脏疼痛疾病,包括间质性膀胱炎/膀胱疼痛综合症和子宫内膜异位症;CNP-104是一种耐受性免疫调节纳米粒子。
Industry: | Biotechnology & Medical Research (NEC) |
100 Summer Street, Suite 2300
BOSTON
MASSACHUSETTS 02110
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球535,000万多名交易者的一份子,选择利用Capital.com进行交易吧。